1134 (1134) Fair Value & Analysis
Healthcare · Market cap HK$173M
Fair value as of: Jul 2, 2026
From 10 valuation models · updated today
Share price −4.2% over the past month.
Price vs Fair Value (12 months)
12‑month range HK$0.1710 – HK$0.3850 · fair‑value band HK$0.0800 – HK$0.0900 · the HK$0.3450 price screens above the HK$0.0900 fair value. As of Jul 2, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
1134 (1134) currently trades at HK$0.3450, while our model-based Fair Value estimate is HK$0.0900 — implying the stock looks roughly 73.9% overvalued today. We read business quality at 69/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, 1134 generated revenue of HK$500M at a net margin of -3.0%. Revenue grew 0.6% year over year. It earns a return on equity of -10.0%. The balance sheet holds a net cash position of HK$39.5M. Fundamentals as of Jul 2, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
1134 reported revenue of HK$500M in FY2025 versus HK$435M in FY2021, a compound +3.6%/yr. Reported net income was −HK$15.1M in FY2025.
Is 1134 fairly valued? → Check now
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.95 | $182.39 | -55% |
| EssilorLuxottica Société anonyme ESLOF | $190.25 | $125.65 | -34% |
| HOYA Corporation HOCPY | $162.33 | $101.00 | -38% |
| Medline Inc MDLN | $33.61 | $31.78 | -5% |
| Becton, Dickinson and Company BDX | $143.92 | $104.17 | -28% |
| Alcon Inc ALC | $66.11 | $36.99 | -44% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is 1134 (1134) undervalued?
What is the fair value of 1134?
What is the quality score of 1134?
What is the revenue of 1134 (1134)?
What is the net profit margin of 1134?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.